Back to News

Life Science Washington VIP Forum with JT Pharma


Cooley – 1700 Seventh Ave Suite 1900
Seattle, WA

Cooley is pleased to support and host the Life Science Washington Forum with JT Pharma. Executives from JT Pharma will be in Seattle February 28 and March 1 for a Plenary Session and 1:1 meetings* with local companies, entrepreneurs, and research groups.

Japan Tobacco 1:1 Meeting Opportunity
JT Pharma is seeking partnering opportunities for collaborative research at early R&D phases, as well as in-licensing opportunities of preclinical - clinical phase assets. JT Pharma is also looking to meet with companies possessing novel, cutting-edge drug R&D technologies.

Collaborative research at early phases
Focus on identification and development of orally active small molecule therapeutics 

Diseases of interest

  • Diabetes
  • Sarcopenia
  • Chronic heart failure
  • Multiple sclerosis
  • Fibrosis
  • HIV latency
  • HBV
  • Dyslipidemia/Atherosclerosis
  • Diabetic complications
  • Non-alcoholic steatohepatitis
  • Peripheral artery disease
  • Inflammatory bowel disease
  • Systemic lupus erythematosus
  • Chronic kidney disease
In-licensing at clinical phases

Focus on development of small molecules, proteins, antibodies, or nucleic acid as therapeutics in Japan

Diseases of interest

  • Renal diseases
  • Allergic diseases
  • Dermatological diseases

Drug R&D technologies 
Technologies related to translational research using cell culture, isolated cellular organelles and related mechanisms; HTS technologies; protein structure analysis; chemical biology, chemical synthesis, and chemical libraries; biophysical tools; in silico technologies; biomarkers and bioinformatics.

Event details and registration

For more information contact Patricia Beckmann.

* There are no fees for either of these events; companies and groups chosen for 1:1 meetings must be Life Science Washington members.